NSAIDs vs placebo
The review found no eligible studies for this question.
- Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether NSAID changes requirements for additional medication compared with placebo (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether recombinant luteinizing hormone (rLH) combined with recombinant… changes live birth rate compared with rFSH alone (very low certainty).
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in OHSS incidence compared with rFSH alone (low certainty).
Recombinant luteinizing hormone (rLH) combined with recombinant… probably leads to higher ongoing pregnancy rate compared with rFSH alone (moderate certainty).
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in miscarriage rate compared with rFSH alone (moderate certainty).
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in cancellation rate for low response compared with rFSH alone (low certainty).
It is very uncertain whether recombinant luteinizing hormone (rLH) combined with recombinant… changes cancellation rate for imminent OHSS compared with rFSH alone (very low certainty).
Combined oral contraceptive pill probably leads to lower live birth or ongoing pregnancy (COCP + Ant vs Ant) compared with no pretreatment (moderate certainty).
Progestogen showed no clear difference in live birth or ongoing pregnancy (Prog + Ant vs Ant) compared with placebo or no pretreatment (low certainty).
Progestogen showed no clear difference in pregnancy loss (Prog + Ag vs Ag) compared with placebo or no pretreatment (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Oestrogen showed no clear difference in live birth or ongoing pregnancy (Oestr + Ant vs Ant) compared with no pretreatment (moderate certainty).
It is very uncertain whether oestrogen changes pregnancy loss (Oestr + Ant vs Ant) compared with no pretreatment (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.